About GF HEALTHCARE Company

Jinwei Medical Group Co., Ltd. (8143.HK) is a Hong Kong listed investment holding group company dedicated to medical investment and hospital management in mainland China and overseas. Through capital leverage, the company actively introduces advanced medical technology, management models and service concepts from abroad, combines the development status of the domestic medical industry, and provides diversified hospital management solutions to the market through various channels such as mergers and acquisitions cooperation, management consulting, special planning, professional training, and entrustment management, and is determined to make Jinwei Medical the preferred brand for hospital operation and management in China. Using the advantages and resources of listed companies, Jinwei Medical Group entered the medical and health care market in the early stages of development through various forms such as mergers and acquisitions, cooperation, trusteeship, franchise, and construction, and construction, and various diagnosis and treatment services, forming a unique medical specialty technology, and applied it to a unique national chain of medical institutions to build a competitive medical service industry network to maximize the different needs of the domestic public for medical services. Jinwei Medical hopes to have a certain number of general hospitals and specialty hospital chains in the future, build the group's main industrial platform, complete the true layout of medical chain institutions, and play an important role in China's medical and health care industry. Jinwei Medical Group has now established strategic cooperative relationships with many medical colleges, scientific research institutions and medical service institutions at home and abroad. It has built an expert pool composed of academic leaders from the United States, the United Kingdom, Canada, Hong Kong, Taiwan, and China. At the same time, it also carries out leading-level basic and clinical medical research to form a competitive intellectual property and characteristic service model in the medical industry to ensure the long-term sustainable development of Jinwei Medical. Jinwei Medical's success and rapid development is based on its professional management team and dedicated employees. The company's management team consists of professionals who have been working in the medical service industry at home and abroad for a long time and have rich management experience. They not only have a broad international perspective, but also have extensive industry and government connections. Under the leadership of the Group's board of directors, the company's management has fully proven its mergers and acquisitions capabilities and level of management. In particular, they have shown impressive skills and foresight in integrating domestic M&A hospitals, and have been able to ensure that Jinwei Healthcare continues to develop rapidly. Currently, many medical institutions under Jinwei Medical have hundreds of experts and special talents with authoritative positions in various major medical technology fields. Their level of medical technology and user-friendly service concept have formed a unique brand at the hospital location, which is an indispensable support and driving force for the continuous development of the Group's hospitals. Through strong capital leverage and advanced hospital management experience, accurate hospital service positioning, effective cost control and advanced management experience, etc., Jinwei Medical has initially formed a characteristic “Jinwei Medical Model” in the Chinese medical industry, adapting to the current national conditions of China's medical and health care development, and has been recognized by the industry, market and government. It has become a model that the Group can replicate, develop, and promote, and truly achieve healthy capital expansion while contributing to the development and upgrading of China's medical and health care industry. Adhering to the millennial Jinwei civilization, Jinwei Medical is committed to the development and dedication of China's healthcare industry by leveraging the strong capital leverage and advanced medical technology and management experience of listed companies.